Zoe Menaspà

Zoe Menaspà

Auto-generated profile, based on publicly available information

Zoe Menaspà

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2022 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
Marialuisa GandolfiMarialuisa Gandolfi
Marialuisa Gandolfi
ASAngela Sandri
Angela Sandri
CGChristian Geroin
Christian Geroin
FBFederica Bombieri
Federica Bombieri
MRMarianna Riello
Marianna Riello
MTMichele Tinazzi
Michele Tinazzi
Background: Functional motor disorders (FMDs) are highly disabling conditions associated with long-term disability, poor quality of life, and economic burden on health and social care. While multidisciplinary 5-days rehabilitation programs have been shown to reduce motor and non-motor symptoms, long-term management and monitoring in FMDs remain an unmet need. Aim: To compare a 12-weeks telemedicine program against a 12-weeks self-management program after a 5-days rehabilitation program for improving motor, non-motor symptoms, quality of life, and perception of change in patients with FMDs. Methods: The study population was 64 consecutive patients with a definite diagnosis of FMDs who underwent a 5-days in-person rehabilitation program followed by either a self-management (the first 32 patients) or a telemedicine program (the latter 32 patients). Validated measures of motor and non-motor symptoms such as fatigue and pain, quality of life, perception of change, gait, and postural control were recorded before (T0), after completion of rehabilitation (T1), and then again at 3 months (T2). Results: Improvement at 3-month follow-up assessment of motor symptoms (p < 0.001), physical fatigue (p = 0.028), and self-rated change perception (p = 0.043) was greater in the telemedicine group. No different between-groups effect was found on other dimensions of fatigue, pain, physical and mental health, and gait and postural control. Conclusions: Long-term management and expert monitoring of patients with FMDs via telemedicine may enhance long-term outcomes in motor symptoms and physical fatigue, with a positive long-term impact on self-rated health perception of change.

12 March 2024 in Clinical Parkinsonism & Related Disorders
Verified
Journal Article
Open access
Marialuisa GandolfiMarialuisa Gandolfi
Marialuisa Gandolfi
CGChristian Geroin
Christian Geroin
Gabriele ImbalzanoGabriele Imbalzano
Gabriele Imbalzano
SCSerena Camozzi
Serena Camozzi
ZMZoe Menaspà
Zoe Menaspà
Carlo Alberto ArtusiCarlo Alberto Artusi
Carlo Alberto Artusi
• Axial postural abnormalities are common complications in Parkinson's Disease with elusive management. • The multifactorial nature of axial postural abnormalities calls for an interdisciplinary approach based on common, consensus-based assessment and diagnostic criteria. • Many interventions can be considered, including medical therapy, physiotherapy, botulinum toxin, and deep brain stimulation. • Without guidelines, a tailored and multidisciplinary approach should be provided from the early phases of the disease.

5 September 2025 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
Marialuisa GandolfiMarialuisa Gandolfi
Marialuisa Gandolfi
SLStefano Landi
Stefano Landi
ASAngela Sandri
Angela Sandri
IVIlaria Antonella Di Vico
Ilaria Antonella Di Vico
CGChristian Geroin
Christian Geroin
CLChiara Leardini
Chiara Leardini
Background Functional motor disorders (FMD) cause long-term disability and economic burden. There is a need for multidisciplinary interventions to manage both motor and non-motor symptoms. We aim to evaluate the clinical and economic effects of integrating digital telemedicine into multidisciplinary FMD management. Methods This single-blind, randomised controlled trial involved patients with FMD. They were randomly assigned to receive 5-day multidisciplinary rehabilitation with either a digital telemedicine or a standard care programme. The digital telemedicine group received remote management and wearable sensors. A blinded evaluator assessed primary and secondary outcomes at baseline, post-treatment, 12-week and 24-week follow-ups. The primary outcomes were changes in motor symptoms. The secondary outcomes were changes in non-motor symptoms, quality of life (QoL) and mobility in unsupervised settings. The incremental cost-effectiveness ratio (ICER) and quality-adjusted life years (QALYs) were calculated at 24 weeks. Results Of the total of 62 patients, half made up the digital telemedicine group (n=31, 40.82% female, mean age 42.55±12.65 years) and half the standard care group (n=31, 59.18% female, mean age 43.77±14.44 years). The mental QoL score for the standard care group was lower (p=0.045) and declined compared with the digital telemedicine group (p=0.034), with lower scores at follow-up (p=0.03). At 24 weeks, the ICER (€5503/QALY) showed that digital telemedicine, despite higher initial costs, yielded 0.037 additional QALYs and reduced healthcare use during follow-up. Conclusions Despite similar improvements in motor symptoms in both groups, digital telemedicine offers an effective adjunct to maintain mental health QoL and reduces healthcare costs in the long-term management of FMD. Trial registration number ClinicalTrials.gov ID: NCT05345340.